 |
- Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence (2023-2026)
- Natalion: Natural Products Research at Latvian Institute of Organic Synthesis as a driver for Excellence in Innovation (2023-2027)
- Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities (2022-2025)
- ISIDORe: Integrated Services for Infectious Disease Outbreak Research (2022 -2025)
 |
- Oligomers-MAS-NMR: Structure determination of amyloid oligomers, the pathogenic species in Alzheimer’s disease using fast MAS NMR and microfluidics (2021-2023)
- A4L_ACTIONS: Alliance for Life Sciences – From Strategies to Actions in Central and Eastern Europe (2021-2024)
- RISK-HUNT3R: Risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs (2021-2026)
- ALISE: Antibody Light-Induced Selectivity Enhancement (2021-2025)
- BBCE: Baltic Biomaterials Centre of Excellence (2020-2026)
- ERA4TB: European Regimen Accelerator for Tuberculosis (2020-2025)
- SPRINGBOARD: Springboard for excellence in advanced development of antibacterials (2020-2023)
- InterTAU: Integrative Structural Biology of Pathological tau Protein, an Appealing Therapeutic Target for Alzheimer´s Disease Modifying Drugs (2020-2023)
- FAT4BRAIN: Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in neurological disorders (2019-2022)
ESIF projects
- PhOAMS: Photocontrol of cell adhesion mechanism (2021-2023)
- BioDrug: Biotechnology at Latvian Institute of Organic Synthesis to Achieve Excellence in Drug Discovery (2019-2023)
 |
| ERA-NET Projects |
- (2023-2025)
- TENTACLES: Temperature-responsive Nanogels for Targeted Delivery of MicroRNAs in Wound Healing and Tissue Regeneration Applications (2020-2023)
- NANO4GLIO: Nanomedicine for Glioblastoma Therapy (2020-2022)
- RESET-ME: Restoring E. coli Sensitivity for Antibiotics by Blocking TolC-Mediated Efflux (2019-2022)
- EXPLORE: Exploration of the TPP Riboswitch as a New Target for Antibiotics (2019-2022)
 |
- ANDRONET: European andrology network– research coordination, education and public awareness (2021-2025)
- TEATIME: Improving biomedical research by automated behaviour monitoring in the animal home-cage (2021-2025)
- VOICES: Making Early Career Investigators’ Voices Heard for Gender Equality (2021-2025)
- Mye-InfoBank: Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (2021-2025)
- ERNEST: European Research Network on Signal Transduction (2019-2023)
- European Cholangiocarcinoma Network (2019-2023)
- New diagnostic and therapeutic tools multidrug resistant tumors (2018-2022)
- INNOGLY: Innovation with Glycans: new frontiers from synthesis to new biological targets (2019-2023)
- GLYCONanoPROBES: Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes (2019-2023)
- Nano2Clinic: Cancer nanomedicine – from the bench to the bedside (2018-2022)
 |
SYNSTAR: Synergistic Stimulation of Adrenergic Receptors for the Treatment of Obesity (2020-2023)